Emerging Drugs for Myelofibrosis

Expert Opinion on Emerging Drugs - United Kingdom
doi 10.1517/14728214.2012.748748
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Informa Healthcare

Related search

Ruxolitinib as an Emerging Treatment in Myelofibrosis

Blood and Lymphatic Cancer: Targets and Therapy
2013English

Emerging Drugs for Obesity Therapy

Arquivos Brasileiros de Endocrinologia & Metabologia
2009English

Emerging Drugs for Idiopathic Pulmonary Fibrosis

Expert Opinion on Emerging Drugs
Pharmacology
2011English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Emerging Drugs for Sickle Cell Anemia

Expert Opinion on Emerging Drugs
Pharmacology
2014English

Emerging Drugs for the Treatment of Anxiety

Expert Opinion on Emerging Drugs
Pharmacology
2015English

Emerging Trabecular Outflow Drugs

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2014English

K2P Channels: Emerging Targets for Novel Analgesic Drugs

British Journal of Pharmacology
Pharmacology
2018English

Phosphodiesterase-5 Inhibitors: Emerging Nephroprotective Drugs

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy